Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Business (3)
97 Articles Available
3
5
Can't find what you're looking for? Try our
advanced search
.
Acquisition
Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.
PR-M09-18-NI-028
Acquisition
Nuvo Pharmaceuticals™ Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
PR-M09-18-NI-011
Licensing Agreement
Cancer Prevention Pharmaceuticals Completes North American Licensing Deal with Mallinckrodt
PR-M09-18-NI-008
Neuroprotective Therapies
Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies
PR-M09-18-NI-004
Generics
FDA Approves First Generic Drug Under New Pathway Aimed at Enhancing Market Competition for Sole Source Drugs
PR-M08-18-NI-108
Acquisition
Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash
PR-M08-18-NI-107
Agreement
NuCryo Vascular Announces Commercialization Agreement with Lokai Medical for Innovative Treatment for Peripheral Arterial Disease
PR-M08-18-NI-105
Collaboration
Trans-Hit Bio Signs an Exclusive Commercial Agreement with the Biobank of the Maricopa Integrated Health System (MIHS) to Support Industry R&D
PR-M08-18-NI-104
Collaboration
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
PR-M08-18-NI-102
Business
Perrigo to Divest Its Prescription Drug Business
PAO-M08-18-NI-015
Market Intelligence
Forces Driving Growth in the U.S. Surgical Microscopes Market
PAO-08-18-CL-001
Investment
Investing in Chinese Pharma Companies Proves Profitable
PR-M05-18-NI-023
Mergers & Acquisitions
Inside Mergers & Acquisitions
PAP-Q2-18-CL-001
Investment
Taking Middle-Market CROs and CDMOs to the Next Level
PAP-Q2-18-CL-003
Corporate Social Responsibility
Corporate Social Responsibility as a Driver for Improved Sustainability
PAP-Q2-18-CL-014
Cell and Gene Therapy
Oxford BioMedica is Making Big Moves
PAO-M03-18-NI-012
Strategic Collaboration
Driving Change in the Pharma Industry and Biotech One Relationship at a Time
PAP-Q1-18-CL-004
Business
DSM Sinochem Pharmaceuticals Is for Sale
PAO-M03-18-NI-009
Business
Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases
PR-M01-18-NI-009
Business
PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors
PR-M01-18-NI-007
Acquisition
Nuvo Pharmaceuticals Inc.™ Acquires Global ex-U.S. Product Rights and existing Royalty Streams to Resultz® from Piedmont Pharmaceuticals LLC
PR-M01-18-NI-006
Business
Cue Biopharma Announces Closing of Initial Public Offering
PR-M01-18-NI-003
Clinical Trials
Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018
PR-M01-18-NI-002
Immuno-Oncology Therapies
ARMO BioSciences Files Registration Statement for Proposed Initial Public Offering
PR-M01-18-NI-001
«
3
5
»
.svg)